Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience

被引:0
|
作者
Lupone, G. [1 ]
Antonino, A. [2 ]
Rosato, A. [3 ]
Zenone, P. [1 ]
Iervolino, E. M. [1 ]
Grillo, M. [1 ]
De Palma, M. [1 ]
机构
[1] Antonio Cardarelli Hosp, Endocrine & Gen Surg Unit, Naples, Italy
[2] Federico II Univ Napoli, Antonio Cardarelli Hosp, Dept Gen Surg Geriatr Oncol & Adv Technol, Naples, Italy
[3] Federico II Univ Napoli, Antonio Cardarelli Hosp, Dept Gen & Endocrine Surg, Naples, Italy
来源
GIORNALE DI CHIRURGIA | 2012年 / 33卷 / 11-12期
关键词
Medullary thyroid carcinoma; Total thyroidectomy; Neck dissection;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Medullary thyroid carcinoma (MTC) is a rare disease which accounts for approximately 5-9% of all thyroid cancers and originates from the calcitonin-secerning parafollicular C cells. MTC can be divided into two subgroups: sporadic (75%) or inherited (25%). The majority of patients with invasive MTC have metastasis to regional lymph nodes at the time of diagnosis, as evidenced by the frequent finding of persistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the cervical lymph nodes reported in retrospective studies. Objectives. The purpose of the study is to review our single institution's experience with MTC since 1998 and to evaluate surgical strategy, patterns of lymph node metastases and calcitonin response to compartment-oriented lymphadenectomy in patients with primary or recurrent sporadic medullary thyroid carcinoma. Methods. A retrospective review of 26 patients treated for MTC at the "Antonio Cardarelli" Hospital referral center, in Naples, between 1998 and 2012. There were 18 female and 8 male patients, median age at presentation was 55 years, and median follow-up for survivors was 5 years. Total thyroidectomy was performed in all 26 patients; central compartment (CC) node dissection ( level VI) in 12 (46%) patients; central plus lateral compartment (LC) node dissection (levels II, III, and IV) in 7 (27%) patients. 4 patients (15%) underwent reoperation for loco-regional recurrent/persistent MTC. Results. After a median post-surgical follow-up of 5 years (range 110 years), 63 % of patients were living disease-free, 15% were living with disease and/or persistently elevated calcitonin levels after surgery, 11% were deceased due to MTC and 11 % were lost to follow-up. Conclusions. We agree with most authors advocating for a total thyroidectomy and prophylactic central neck dissection in the setting of clinically detected MTC. Lateral neck dissection may be best reserved for patients with positive preoperative imaging. Nevertheless MTC has a high rate of lymph node metastases that are sub optimally detected preoperatively in the central compartment by neck ultrasound or intra-operatively by the surgeon, and reoperation is associated with a higher rate of surgical complications. In our limited experience, patients with thyroid confined nodular pathology, without nodal disease and unknown preoperative diagnosis of MTC, underwent only total thyroidectomy with a good prognosis.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 50 条
  • [41] Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma
    Gimm, O
    Sutter, T
    Dralle, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (03) : 156 - 165
  • [42] Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma
    Qu, Ning
    Shi, Xiao
    Zhao, Jing-Jing
    Guan, Haixia
    Zhang, Ting-Ting
    Wen, Shi-Shuai
    Liao, Tian
    Hu, Jia-Qian
    Liu, Wei-Yan
    Wang, Yu-Long
    Huang, Shenglin
    Shi, Rong-Liang
    Wang, Yu
    Ji, Qing-Hai
    THYROID, 2020, 30 (07) : 1025 - 1036
  • [43] Current approaches to medullary thyroid carcinoma, sporadic and familial
    Fialkowski, Elizabeth A.
    Moley, Jeffrey F.
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (08) : 737 - 747
  • [44] Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
    Matrone, Antonio
    Gambale, Carla
    Prete, Alessandro
    Elisei, Rossella
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [45] Sporadic and Familial Medullary Thyroid Carcinoma: State of the Art
    Moo-Young, Tricia A.
    Traugott, Amber L.
    Moley, Jeffrey F.
    SURGICAL CLINICS OF NORTH AMERICA, 2009, 89 (05) : 1193 - +
  • [46] Choroidal metastasis from sporadic medullary thyroid carcinoma
    Rosário, F
    Garrao, A
    Laranjeira, J
    Bugalho, MJ
    Limbert, E
    Sobrinho, LG
    THYROID, 2005, 15 (12) : 1401 - 1402
  • [47] Surgical management of medullary thyroid carcinoma
    Konstantinidis, Agathoklis
    Stang, Michael
    Roman, Sanziana A.
    Sosa, Julie Ann
    UPDATES IN SURGERY, 2017, 69 (02) : 151 - 160
  • [48] Surgical management of medullary thyroid carcinoma
    Agathoklis Konstantinidis
    Michael Stang
    Sanziana A. Roman
    Julie Ann Sosa
    Updates in Surgery, 2017, 69 : 151 - 160
  • [49] Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma
    Oliver Gimm
    Thomas Sutter
    Henning Dralle
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 156 - 165
  • [50] Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
    Frank-Raue, Karin
    Machens, Andreas
    Leidig-Bruckner, Gudrun
    Rondot, Susanne
    Haag, Christine
    Schulze, Egbert
    Lorenz, Angela
    Kreissl, Michael C.
    Dralle, Henning
    Raue, Friedhelm
    Schmid, Kurt W.
    THYROID, 2013, 23 (03) : 294 - 300